🚨 Bioverge Access Fund 4 is now accepting investors! Leverage Bioverge expertise and back 15 leading healthcare startups through a single investment. Learn more and invest
Nlc 500 wide

Team Up with a Force for Good

NLC, founded in 2015, is a new breed of healthtech venture builder that has been awarded B-Corp certification in 2020. By using entrepreneurship at scale, they bring together the best tech, the best people, and the best capital to build life-changing healthtech ventures.

Sketched graphic
Build Ventures. Advance Health.

NLC estimates that 95% of science-based healthtech inventions never reach the patient, while bringing them to the market would be life-changing for many. To advance health, accessible for everyone, NLC gives investors unique access to early-stage research developments. It’s a rare opportunity to shape the future of medical technology.